335 related articles for article (PubMed ID: 25962058)
1. Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.
Lhoumeau AC; Martinez S; Boher JM; Monges G; Castellano R; Goubard A; Doremus M; Poizat F; Lelong B; de Chaisemartin C; Bardin F; Viens P; Raoul JL; Prebet T; Aurrand-Lions M; Borg JP; Gonçalves A
PLoS One; 2015; 10(5):e0123768. PubMed ID: 25962058
[TBL] [Abstract][Full Text] [Related]
2. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
3. Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer.
Gargalionis AN; Korkolopoulou P; Farmaki E; Piperi C; Dalagiorgou G; Adamopoulos C; Levidou G; Saetta A; Fragkou P; Tsioli P; Kiaris H; Zizi-Serbetzoglou A; Karavokyros I; Papavassiliou KA; Tsavaris N; Patsouris E; Basdra EK; Papavassiliou AG
Int J Cancer; 2015 Apr; 136(7):1515-27. PubMed ID: 25123959
[TBL] [Abstract][Full Text] [Related]
4. Expression of SATB1 promotes the growth and metastasis of colorectal cancer.
Zhang Y; Tian X; Ji H; Guan X; Xu W; Dong B; Zhao M; Wei M; Ye C; Sun Y; Yuan X; Yang C; Hao C
PLoS One; 2014; 9(6):e100413. PubMed ID: 24971456
[TBL] [Abstract][Full Text] [Related]
5. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
7. miR‑205‑5p/PTK7 axis is involved in the proliferation, migration and invasion of colorectal cancer cells.
Chen S; Wang Y; Su Y; Zhang L; Zhang M; Li X; Wang J; Zhang X
Mol Med Rep; 2018 May; 17(5):6253-6260. PubMed ID: 29488611
[TBL] [Abstract][Full Text] [Related]
8. PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance.
Tian X; Yan L; Zhang D; Guan X; Dong B; Zhao M; Hao C
Oncol Rep; 2016 Oct; 36(4):1829-36. PubMed ID: 27499181
[TBL] [Abstract][Full Text] [Related]
9. High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma.
Jin J; Ryu HS; Lee KB; Jang JJ
PLoS One; 2014; 9(2):e90247. PubMed ID: 24587299
[TBL] [Abstract][Full Text] [Related]
10. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of CDCP1 Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion and Migration.
Chou CT; Li YJ; Chang CC; Yang CN; Li PS; Jeng YM; Chen ST; Kuo ML; Lin IC; Lin BR
Ann Surg Oncol; 2015 Dec; 22(13):4335-43. PubMed ID: 25820997
[TBL] [Abstract][Full Text] [Related]
12. PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement.
Gärtner S; Gunesch A; Knyazeva T; Wolf P; Högel B; Eiermann W; Ullrich A; Knyazev P; Ataseven B
PLoS One; 2014; 9(1):e84472. PubMed ID: 24409301
[TBL] [Abstract][Full Text] [Related]
13. Comparative integromics on non-canonical WNT or planar cell polarity signaling molecules: transcriptional mechanism of PTK7 in colorectal cancer and that of SEMA6A in undifferentiated ES cells.
Katoh M; Katoh M
Int J Mol Med; 2007 Sep; 20(3):405-9. PubMed ID: 17671748
[TBL] [Abstract][Full Text] [Related]
14. The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome.
Prebet T; Lhoumeau AC; Arnoulet C; Aulas A; Marchetto S; Audebert S; Puppo F; Chabannon C; Sainty D; Santoni MJ; Sebbagh M; Summerour V; Huon Y; Shin WS; Lee ST; Esterni B; Vey N; Borg JP
Blood; 2010 Sep; 116(13):2315-23. PubMed ID: 20558616
[TBL] [Abstract][Full Text] [Related]
15. PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells.
Shin WS; Park MK; Kim JH; Oh SW; Jang JY; Lee H; Lee ST
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216506
[TBL] [Abstract][Full Text] [Related]
16. PTK7 is a novel oncogenic target for esophageal squamous cell carcinoma.
Liu K; Song G; Zhang X; Li Q; Zhao Y; Zhou Y; Xiong R; Hu X; Tang Z; Feng G
World J Surg Oncol; 2017 May; 15(1):105. PubMed ID: 28545451
[TBL] [Abstract][Full Text] [Related]
17. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
[TBL] [Abstract][Full Text] [Related]
18. NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis.
Wu Y; Fang G; Wang X; Wang H; Chen W; Li L; Ye T; Gong L; Ke C; Cai Y
Cancer Biomark; 2019; 24(1):61-70. PubMed ID: 30347601
[TBL] [Abstract][Full Text] [Related]
19. Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis.
Jao TM; Tsai MH; Lio HY; Weng WT; Chen CC; Tzeng ST; Chang CY; Lai YC; Yen SJ; Yu SL; Yang YC
Int J Cancer; 2014 Dec; 135(11):2593-603. PubMed ID: 24740680
[TBL] [Abstract][Full Text] [Related]
20. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development.
Piao MY; Cao HL; He NN; Xu MQ; Dong WX; Wang WQ; Wang BM; Zhou B
Scand J Gastroenterol; 2016; 51(5):572-82. PubMed ID: 26691157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]